Cash Flows Statements (USD $) In Millions, unless otherwise specified	3 Months Ended		9 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2013	Mar. 31, 2012
Operations
Net income	$ 6,055	$ 5,108	$ 16,898	$ 17,470
Adjustments to reconcile net income to net cash from operations:
Depreciation, amortization, and other	1,053	766	2,772	2,170
Stock-based compensation expense	599	591	1,805	1,724
Net recognized losses (gains) on investments and derivatives	(52)	68	(19)	(74)
Excess tax benefits from stock-based compensation	(6)	(10)	(192)	(84)
Deferred income taxes	226	(134)	404	282
Deferral of unearned revenue	9,686	8,142	28,632	21,825
Recognition of unearned revenue	(11,599)	(8,283)	(30,852)	(23,993)
Changes in operating assets and liabilities:
Accounts receivable	2,191	2,770	3,859	3,851
Inventories	(483)	(50)	(989)	(79)
Other current assets	139	73	(96)	938
Other long-term assets	(13)	9	(326)	(36)
Accounts payable	(67)	(114)	51	(380)
Other current liabilities	1,238	492	119	(107)
Other long-term liabilities	699	166	864	442
Net cash from operations	9,666	9,594	22,930	23,949
Financing
Proceeds from issuance of debt	0	0	2,232	0
Common stock issued	203	1,091	765	1,635
Common stock repurchased	(1,028)	(1,023)	(4,318)	(3,999)
Common stock cash dividends paid	(1,925)	(1,683)	(5,534)	(4,707)
Excess tax benefits from stock-based compensation	6	10	192	84
Other	0	0	(16)	0
Net cash used in financing	(2,744)	(1,605)	(6,679)	(6,987)
Investing
Additions to property and equipment	(930)	(749)	(2,463)	(1,683)
Acquisition of companies, net of cash acquired, and purchases of intangible and other assets	(108)	(84)	(1,564)	(9,586)
Purchases of investments	(18,160)	(23,951)	(48,372)	(45,297)
Maturities of investments	1,265	4,236	4,513	13,122
Sales of investments	9,730	7,946	30,163	23,317
Securities lending payable	543	361	(249)	3
Net cash used in investing	(7,660)	(12,241)	(17,972)	(20,124)
Effect of exchange rates on cash and cash equivalents	(39)	30	23	(60)
Net change in cash and cash equivalents	(777)	(4,222)	(1,698)	(3,222)
Cash and cash equivalents, beginning of period	6,017	10,610	6,938	9,610
Cash and cash equivalents, end of period	$ 5,240	$ 6,388	$ 5,240	$ 6,388